Efficacy of Ravuconazole in Treatment of Systemic Murine Histoplasmosis
Ravuconazole (RCZ) was evaluated for efficacy in comparison to fluconazole (FCZ) and itraconazole (ITZ) in murine models of disseminated histoplasmosis. All regimens tested prolonged survival (P < 0.05 to 0.0001). At equivalent doses of 50 mg/kg of body weight, RCZ and ITZ were equally effective and...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
2002
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127511/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850289/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.922-924.2002 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|